NCT06739616

Brief Summary

The goal of this clinical trial is to demonstrate feasibility of procedures and compare the outcomes of intervention arrangements to reduce sensory based self-injurious behavior exhibited by individuals with intellectual and developmental disabilities. The main question\[s\] it aims to answer are: (1) Demonstrate ability to meet enrollment requirements. (2) Evaluate acceptability and feasibility of participation relative to observation length and study duration. (3) Track and compare participant progress across interventions. (4) Demonstrate acceptable procedural fidelity and interobserver agreement. And (5) conduct post hoc evaluation of clinical presentation and intervention match. Participants will \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items\]. If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\].

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

April 18, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 18, 2024

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

1.4 years

First QC Date

February 8, 2023

Last Update Submit

December 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of Self-Injurious Behavior exhibited by individual participants as measured by direct observation

    Behavior that causes or has potential to cause injury to the participant

    Change in level of SIB from pre-intervention to intervention

Study Arms (2)

Study 1: Longevity

EXPERIMENTAL

Study 1: Longevity will evaluate the impact of matched and unmatched competing stimuli on reinforcement-based interventions as implementation durations are increased. Three conditions will be compared, using within-subjects single case designs: (a) baseline (no intervention), (b) intervention with competing stimuli matched to the hypothesized sensory consequences of SIB, and (c) intervention with competing stimuli unmatched to the hypothesized sensory consequences of SIB. Participants' specific intervention will be either noncontingent reinforcement (NCR) or differential reinforcement of other behavior (DRO), based on the outcomes of the pre-intervention assessments. During NCR, participants will receive access to competing stimuli on an ongoing and response-independent basis. During DRO, participants will receive access to competing stimuli contingent on the omission of SIB for a pre-determined length of time. Implementation will gradually increase up to a maximum of three hours.

Behavioral: AUTOSIB across time

Study 2: Schedule Thinning

EXPERIMENTAL

Study 2: Schedule Thinning will evaluate the impact of matched and unmatched competing stimuli on reinforcement-based interventions as access to reinforcers decreases. Three conditions will be compared, using within-subjects single case designs: (a) baseline (no intervention), (b) intervention with competing stimuli matched to the hypothesized sensory consequences of SIB, and (c) intervention with competing stimuli unmatched to the hypothesized sensory consequences of SIB. Participants' specific intervention will be either noncontingent reinforcement (NCR) or differential reinforcement of other behavior (DRO), based on the outcomes of the pre-intervention assessments. During NCR, participants will receive access to competing stimuli on an ongoing and response-independent basis. During DRO, participants will receive access to competing stimuli contingent on the omission of SIB for a pre-determined length of time. Access to reinforcers will decrease across successful implementations.

Behavioral: AUTOSIB diminished reinforcement

Interventions

Intervention will be in place across increasing time frames.

Study 1: Longevity

Intervention will be in place with decreasing levels of reinforcement

Study 2: Schedule Thinning

Eligibility Criteria

Age2 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • years and older
  • Diagnosis of intellectual and/or developmental disability
  • Referred for assessment and treatment of self-injurious behavior
  • Behavior maintained by automatic reinforcement function

You may not qualify if:

  • Behavior maintained by a social reinforcement (e.g., attention, escape) function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

May Institute

Randolph, Massachusetts, 02368, United States

Location

MeSH Terms

Conditions

Self-Injurious BehaviorProblem BehaviorIntellectual DisabilityAutism Spectrum Disorder

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorChild BehaviorNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental DisordersChild Development Disorders, Pervasive

Study Officials

  • Joel E Ringdahl, PhD

    University of Georgia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single case research design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 8, 2023

First Posted

December 18, 2024

Study Start

April 18, 2023

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

December 27, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

The investigators will upload data to NIMH's National Database for Autism Research (NDAR). This process begins within six months of the award by creating a list of all data expected to be collected in the project using the Data Expected feature in NDAR, completing the NIMH Data Archive Data Submission Agreement form, and providing all necessary materials for any structures not yet defined in the NDA Data Dictionary. Within three months of receiving this information, NDAR contacts the study team to refine the plan for uploading the data. Item-level data for individual subjects are entered into NDAR for all study measures. Researchers are expected to associate the data deposited in NDA with their publications/findings - both positive and negative - using the NDA Study feature so that other researchers can locate the data. NDAR also allows researchers to search for data by study name.

Shared Documents
STUDY PROTOCOL
Time Frame
Descriptive/raw data on subject characteristics are expected to be submitted to NDAR on a semi-annual basis (on or before January 15 and July 15). Outcome data are uploaded at the time of first publication. Data are made publicly available within four months of submission. To ensure timely submission of outcome data, the investigators will monitor data quality on an ongoing basis so that they can lock the dataset within six months after the investigators complete data collection. A report will be submitted of the primary findings for publication in a peer-refereed journal within one year after completed data collection. Because the data will reside at NDAR, they will remain available indefinitely, regardless of whether the investigators remain at their current institutions.
Access Criteria
No specified criteria.

Locations